Fat cell therapy shows promise for Hard-to-Heal gut holes

NCT ID NCT07661043

Not yet recruiting Disease control Sponsor: Asian Institute of Gastroenterology, India Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether injecting a patient's own fat-derived cells can help close abnormal connections (fistulas) in the gut that won't heal with standard treatments. Researchers will track 50 adults to see what factors predict successful closure. The goal is to understand who benefits most from this regenerative approach.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: fat-derived regenerative cells (stromal vascular fraction)
What this could lead to: If successful, this could identify which patients and techniques lead to fistula healing, guiding better use of this regenerative therapy.
What could go wrong: This is a small, early observational study (50 patients) with no control group. It only looks for factors linked to success, not proving the therapy works. Fistulas may not heal or could recur.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN GASTROINTESTINAL FISTULA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Digestive System Fistula Fistula intestinal fistula

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FISTULA REGENERATIVE MEDICINE STROMAL VASCULAR FRACTION

Contacts and locations

Locations

AIG Hospitals

Hyderabad, Telangana, 500075, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.